|
AIMP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11169995431482E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27449947765024E-10 |
| Normal-vs-Stage2 |
7.706400E-01 |
| Normal-vs-Stage3 |
1.75240000288568E-09 |
| Normal-vs-Stage4 |
4.21069956679787E-10 |
| Stage1-vs-Stage2 |
4.993400E-04 |
| Stage1-vs-Stage3 |
5.050800E-01 |
| Stage1-vs-Stage4 |
1.467380E-01 |
| Stage2-vs-Stage3 |
2.760600E-04 |
| Stage2-vs-Stage4 |
7.51800000000635E-05 |
| Stage3-vs-Stage4 |
3.689800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.6781021844613E-11 |
| Normal-vs-AfricanAmerican |
5.68000000034097E-07 |
| Normal-vs-Asian |
4.96550000006479E-07 |
| Caucasian-vs-AfricanAmerican |
6.785800E-01 |
| Caucasian-vs-Asian |
6.089000E-01 |
| AfricanAmerican-vs-Asian |
4.500800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.97000000148984E-08 |
| Normal-vs-Female |
5.3579000125481E-09 |
| Male-vs-Female |
4.649400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50230050621758E-10 |
| Normal-vs-Age(41-60Yrs) |
4.13809997379389E-09 |
| Normal-vs-Age(61-80Yrs) |
3.960600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.122800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.123400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.757500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.039600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.281700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.406200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.769800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.570300E-02 |
| Classical-VS-Follicular |
6.02009999961517E-07 |
| Classical-VS-Other |
4.911400E-01 |
| Classical-VS-Normal |
1.77879933005443E-12 |
| Tall-VS-Follicular |
1.04670000444784E-08 |
| Tall-VS-Other |
9.984200E-01 |
| Tall-VS-Normal |
3.50830475781549E-14 |
| Follicular-VS-Other |
5.516400E-02 |
| Follicular-VS-Normal |
7.041800E-01 |
| Other-VS-Normal |
1.801110E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94134000000012E-05 |
| Normal-vs-N1 |
3.73034936274053E-14 |
| N0-vs-N1 |
6.60760000048555E-07 |
|
|
